Blossomhill Therapeutics Inc (BLSM)

$16.00 +0.25 (1.59%)
Market Cap N/A
Revenue (ttm) N/A
Net Income (ttm) N/A
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume 1,755,831
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts N/A
Price Target N/A
Latest News on BLSM
BlossomHill Therapeutics Stock (BLSM) Fails to Shine After $150M U.S. IPO

2026-08-07T19:07:26.000Z - 3 hours ago

BlossomHill Therapeutics Stock (BLSM) Fails to Shine After $150M U.S. IPO

BMY JPM

BlossomHill Therapeutics opens at $15.75, IPO priced at $16.00

2026-08-07T16:35:37.000Z - 5 hours ago

BlossomHill Therapeutics opens at $15.75, IPO priced at $16.00

BlossomHill Therapeutics 9.375M share IPO priced at $16.00

2026-08-07T03:00:30.000Z - 19 hours ago

BlossomHill Therapeutics 9.375M share IPO priced at $16.00

BlossomHill Therapeutics Announces Pricing of Upsized $150 Million Initial Public Offering

Aug 6, 2026, 8:07 PM EDT - 22 hours ago

BlossomHill Therapeutics Announces Pricing of Upsized $150 Million Initial Public Offering

BlossomHill Therapeutics 7.81M share IPO price range $15.00-$17.00

2026-08-04T09:05:35.000Z - 3 days ago

BlossomHill Therapeutics 7.81M share IPO price range $15.00-$17.00

Latigo, BlossomHill launch US IPOs as biotech listings rebound

Aug 3, 2026, 8:25 AM EDT - 4 days ago

Latigo, BlossomHill launch US IPOs as biotech listings rebound

LTGO

Cancer therapies biotech BlossomHill Therapeutics files for a $100 million IPO

Jul 17, 2026, 12:51 AM EDT - 21 days ago

Cancer therapies biotech BlossomHill Therapeutics files for a $100 million IPO

BlossomHill Therapeutics IPO Registration Document (S-1)

Jul 16, 2026, 8:13 PM EDT - 21 days ago

BlossomHill Therapeutics IPO Registration Document (S-1)